vTv Therapeutics (VTVT) Other Accumulated Expenses (2014 - 2021)

vTv Therapeutics has disclosed Other Accumulated Expenses across 8 years of filings, most recently posting $155000.0 for Q4 2021.

• In Q4 2021, Other Accumulated Expenses rose 675.0% year-over-year to $155000.0; the TTM figure through Dec 2021 stood at $155000.0 (up 675.0% YoY), while the FY2021 annual figure was $155000.0, up 675.0% from the prior year.
• Other Accumulated Expenses came in at $155000.0 for Q4 2021 at vTv Therapeutics, up from $20000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q4 2017 to a low of $20000.0 in Q4 2020.
• Average Other Accumulated Expenses over 5 years is $300400.0, with a median of $142000.0 recorded in 2018.
• Year-over-year, Other Accumulated Expenses plunged 86.55% in 2018 and soared 675.0% in 2021.
• Over 5 years, Other Accumulated Expenses stood at $1.1 million in 2017, then sank by 86.55% to $142000.0 in 2018, then decreased by 9.15% to $129000.0 in 2019, then plunged by 84.5% to $20000.0 in 2020, then soared by 675.0% to $155000.0 in 2021.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $155000.0 in Q4 2021, $20000.0 in Q4 2020, and $129000.0 in Q4 2019.